3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
4
Fallopian Tube Neoplasms
2
Platinum-resistant Ovarian Cancer
1
Ovarian Cancer Recurrent
1
Adenoviridae Infections
1
Interventions
Cyclophosphamide
31
Rituximab
28
Biopsy
23
Specimen Handling
20
Magnetic Resonance Spectroscopy
18
fludarabine
14
Prednisone
14
Vincristine
11
Doxorubicin
11
obinutuzumab
10
Lenalidomide
10
Etoposide
10
Bendamustine Hydrochloride
9
venetoclax
7
pembrolizumab
7
glofitamab
6
fludarabine phosphate
6
X-Rays
6
Tacrolimus
6
Nuclear Medicine Department, Hospital
6
Dexamethasone
6
Bortezomib
6
trametinib
5
ibrutinib
5
acalabrutinib
5
Mycophenolic Acid
5
Gemcitabine
5
Crizotinib
5
Busulfan
5
copanlisib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
1-dodecylpyridoxal
×
90 days
×
Clear all
No trials found.